Accuracy of an Oligonucleotide-Based Fluorescence In Situ Hybridization (FISH) Urine Assay: Prospective Study of 389 Patients Monitored for Recurrence of Bladder Cancer

被引：0
|
作者：
Bostwick, D. G. [1 ]
Hossain, D. [1 ]
机构：
[1] Bostwick Labs Inc, Orlando, FL USA
来源：
MODERN PATHOLOGY | 2013年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
820
引用
收藏
页码：199A / 199A
页数：1
相关论文
共 50 条
  • [41] Prospective Study Evaluating the Role Of UroVysion (Fluorescence In Situ Hybridization) Assay in the Diagnosis of Upper Tract Urothelial Carcinomas (UTUC) Combined with the Paris System for Reporting Urine Cytology
    Baig, Ayesha
    Brimo, Fadi
    Lavoie, Josee
    Blumenkrantz, Miriam
    Kanber, Yonca
    Caglar, Derin
    Kassouf, Wassim
    Andonian, Sero
    Auger, Manon
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 328 - 328
  • [42] Telomere length on bladder washing samples from patients with bladder cancer correlates with tumor characteristics flow cytometry method for quantitative fluorescence in situ hybridization (flow-FISH technique)
    Fernandez-Gomez, J
    Barmadah, SE
    Gosalbez, D
    Rodriguez-Faba, O
    Jalon, A
    Gonzalez, R
    Miralles, TG
    Calas, A
    EUROPEAN UROLOGY, 2005, 48 (03) : 432 - 437
  • [43] Evaluation of the Fluorescence In Situ Hybridization Test to Predict Recurrence and/or Progression of Disease after bacillus Calmette-Guerin for Primary High Grade Nonmuscle Invasive Bladder Cancer: Results from a Prospective Multicenter Trial
    Lotan, Yair
    Inman, Brant A.
    Davis, Leah Gerber
    Kassouf, Wassim
    Messing, Edward
    Daneshmand, Siamak
    Canter, Daniel
    Marble, H. Tony
    Joseph, Ajith M.
    Jewell, Susan
    Boorjian, Stephen A.
    JOURNAL OF UROLOGY, 2019, 202 (05): : 922 - 928
  • [44] Prospective study to evaluate the sensitivity and specificity of ADX-Bladder and EpiCheck tests against urine cytology to detect early tumor recurrence in patients with non-muscle invasive bladder cancer
    Rodriguez Serrano, A.
    Duque, M.
    Rodriguez Garcia, A. M.
    Alvarez-Maestro, M.
    Linares-Espinos, E.
    Solano, P.
    Martinez-Pineiro, L.
    EUROPEAN UROLOGY, 2023, 83 : S388 - S389
  • [45] A novel algorithm for the EGFR fluorescence in situ hybridization (FISH) assay in non-small cell lung cancer: an analysis of the NCIC Clinical Trials Group Study BR.21
    Santos, Gilda C.
    Ding Keyue
    Cutz, Jean-Claude
    Le Maitre, Aurelie
    Squire, Jeremy A.
    Shepherd, Frances A.
    Tsao, Ming S.
    Seymour, Lesley
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S924 - S925
  • [46] Potential of an mRNA-Based Urine Assay (Xpert® Bladder Cancer Detection1) in Hematuria Patients - Results from a Cohort Study
    Schmitz-Draeger, Claudia
    Goebell, Peter J.
    Paxinos, Ellen
    Bismarck, Ekkehardt
    Chen, Jack
    Balakrishnan, Priya
    Bates, Michael
    Ebert, Thomas
    Schmitz-Draegera, Bernd J.
    Benderska-Soeder, Natalya
    BLADDER CANCER, 2024, 10 (01) : 25 - 33
  • [47] Editorial Comment from Dr Todenhofer and Dr Schwentner to Recurrence and progression in patients with non-muscle invasive bladder cancer: Prognostic models including multicolor fluorescence in situ hybridization molecular grading
    Todenhoefer, Tilman
    Schwentner, Christian
    INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 (10) : 973 - 973
  • [48] Genetically Abnormal Circulating Cells in Lung Cancer Patients: An Antigen-Independent Fluorescence In situ Hybridization-Based Case-Control Study
    Katz, Ruth L.
    He, Weigong
    Khanna, Abha
    Fernandez, Ricardo L.
    Zaidi, Tanweer M.
    Krebs, Matthew
    Caraway, Nancy P.
    Zhang, Hua-Zhong
    Jiang, Feng
    Spitz, Margaret R.
    Blowers, David P.
    Jimenez, Carlos A.
    Mehran, Reza J.
    Swisher, Stephen G.
    Roth, Jack A.
    Morris, Jeffrey S.
    Etzel, Carol J.
    El-Zein, Randa
    CLINICAL CANCER RESEARCH, 2010, 16 (15) : 3976 - 3987
  • [49] Re: Evaluation of the Fluorescence In Situ Hybridization Test to Predict Recurrence and/or Progression of Disease after bacillus Calmette-Guerin for Primary High Grade Nonmuscle Invasive Bladder Cancer: Results from a Prospective Multicenter Trial Reply
    不详
    JOURNAL OF UROLOGY, 2020, 203 (03): : 625 - 626
  • [50] Response to Editorial Comment from Dr Todenhofer and Dr Schwentner to Recurrence and progression in patients with non-muscle invasive bladder cancer: Prognostic models including multicolor fluorescence in situ hybridization molecular grading
    Lodde, Michele
    Mian, Christine
    Mayr, Roman
    Comploj, Evi
    Trenti, Emanuela
    Melotti, Roberto
    Campodonico, Fabio
    Maffezzini, Massimo
    Fritsche, Hans-Martin
    Pycha, Armin
    INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 (10) : 974 - 975
12345